Skip to content

Relevance of Reactive Hypoglycemia During an OGTT in Everyday Life Using Continuous Glucose Measurement

Evaluation of the Everyday Relevance of Reactive Hypoglycemia in the Oral Glucose Tolerance Test Using Continuous Glucose Measurement.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06182527
Acronym
HypoCGM
Enrollment
21
Registered
2023-12-27
Start date
2023-12-27
Completion date
2025-08-12
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoglycemia, Reactive

Keywords

Reactive Hypoglycemia, Oral glucose tolerance test, Continuous glucose monitoring

Brief summary

This research project aims to investigate the everyday relevance of reactive hypoglycemia (hypoglycemia after a glucose load) in the oral glucose tolerance test (OGTT). Therefore, blood glucose profiles in everyday life will be examined using continuous glucose measurement (Free Style Libre PRO IQ system) over a period of 14 days in affected persons.

Detailed description

The aim of this analysis is to examine people who underwent an OGTT due to various endocrinological and metabolic issues and developed reactive hypoglycemia, defined as a drop in blood glucose \<70mg/dl during the course of the test. During OGTT routine laboratory testing will be performed as part of routine clinical practice. In order to investigate the occurrence and perception of hypoglycaemia in the everyday lives of those affected, their blood glucose profiles will be recorded and evaluated over a period of 14 days. In addition, the perception of (suspected) hypoglycemia and counteraction will be documented. Anthropometric data will be recorded and a bioelectrical impedance analysis performed to check a correlation with the body composition. Subjects will be recruited via the endocrinology outpatient clinic as part of medical care. To date, very little CGM data are available on the frequency and extent of reactive hypoglycemia in the everyday lives of people without diabetes mellitus. Therefore, 20 subjects with hypoglycemia in the OGTT will be included in this exploratory pilot study for hypothesis generation in order to investigate the occurrence and perception of hypoglycemia in everyday life.

Interventions

DEVICEFree Style Libre Pro IQ

Every participant receives a Free Style Libre Pro IQ sensor for 14 days. Glucose levels will be recorded.

Sponsors

University of Ulm
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Masking description

Every participant receives a Freestyle Libre PRO IQ Sensor, a system which ensures blinding of the glucose levels to the participants.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* hypoglycemia during a 75 g oral glucose tolerance test defined as glucose level below 70 mg/dl at timepoint 180 min. * written consent

Exclusion criteria

* diabetes mellitus * use of medication interfering with glucose metabolism (steroid, antidiabetic medications) * surgery of upper GI-tract * known plaster allergies * any other clinical condition that would endanger participants safety or question scientific success according to the physicians opinion

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of hypoglycemia14 daysOccurrence of glucose levels below 70 mg/dl assessed by CGM.
Frequency of hypoglycemia14 daysNumber of glucose levels below 70 mg/dl assessed by CGM.
Severity of hypoglycemia14 daysNon-severe hypoglycemia defined as glucose levels \< 70 mg/dl but \>= 54mg/dl; severe hypoglycemia defined as glucose levels \< 54mg/dl assessed by CGM.

Secondary

MeasureTime frameDescription
Mean glucose levels14 daysMean glucose levels during monitoring period assessed by CGM.
Glucose variability14 daysGlucose variability during monitoring period assessed by CGM.
Time of occurence of hypoglycemia14 daysOccurence of hypoglycemia during day or night time and correspondence to food intake assessed by CGM.
Correlation between body composition and hypoglycemia in everyday life14 daysCorrelation between body composition (assessed by bioelectrical impedance analysis and anthropometric measurements) and incidence as well as severity of hypoglycemia in everyday life assessed by CGM.
Correlation between severity of hypoglycemia during ogtt and hypoglycemia in everyday lifeVarying time point between oGTT and 14 days of glucose assessment using CGMCorrelation between severity of hypoglycemia during OGTT and incidence and severity of hypoglycemia in everyday life assessed by CGM.
Perception of hypoglycemia14 daysIncidence of typical symptoms of hypoglycemia perceived by the participant, documented in a protocol with free-text fields handed out to the participant during 1st study visit.
Time in predefined glucose ranges14 daysTime spent in the following glucose ranges: time above range: \>140mg/dl; time in range: 71-140mg/dl; time below range: \<70mg/dl; time with severe hypoglycemia: \<54mg/dl assessed by CGM.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026